Paul R Edick - Net Worth and Insider Trading
Paul R Edick Net Worth
The estimated net worth of Paul R Edick is at least $4 Million dollars as of 2024-04-19. Paul R Edick is the See Remarks of Xeris Biopharma Holdings Inc and owns about 2,321,494 shares of Xeris Biopharma Holdings Inc (XERS) stock worth over $4 Million. Paul R Edick is also the Director of Iterum Therapeutics PLC and owns about 1,682 shares of Iterum Therapeutics PLC (ITRM) stock worth over $2,405. Details can be seen in Paul R Edick's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Paul R Edick has not made any transactions after 2023-08-09 and currently still holds the listed stock(s).
Transaction Summary of Paul R Edick
Paul R Edick Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul R Edick owns 7 companies in total, including Milestone Pharmaceuticals Inc (MIST) , Xeris Biopharma Holdings Inc (XERS) , and Iterum Therapeutics PLC (ITRM) among others .
Click here to see the complete history of Paul R Edick’s form 4 insider trades.
Insider Ownership Summary of Paul R Edick
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MIST | Milestone Pharmaceuticals Inc | 2019-05-08 | director |
| XERS | Xeris Biopharma Holdings Inc | 2023-08-09 | director & See Remarks |
| ITRM | Iterum Therapeutics PLC | 2019-05-24 | director |
| PDLI | PDL BioPharma Inc | 2018-06-08 | director |
| SCMP | Sucampo Pharmaceuticals Inc | 2018-02-13 | director |
| NEOS | Neos Therapeutics Inc | 2017-07-03 | director |
| LUMO | Lumos Pharma Inc | 2012-01-19 | director |
Paul R Edick Latest Holdings Summary
Paul R Edick currently owns a total of 2 stocks. Among these stocks, Paul R Edick owns 2,321,494 shares of Xeris Biopharma Holdings Inc (XERS) as of August 9, 2023, with a value of $4 Million and a weighting of 99.94%. Paul R Edick also owns 1,682 shares of Iterum Therapeutics PLC (ITRM) as of August 23, 2018, with a value of $2,405 and a weighting of 0.06%.
Latest Holdings of Paul R Edick
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XERS | Xeris Biopharma Holdings Inc | 2023-08-09 | 2,321,494 | 1.76 | 4,085,829 |
| ITRM | Iterum Therapeutics PLC | 2018-08-23 | 1,682 | 1.43 | 2,405 |
Holding Weightings of Paul R Edick
Paul R Edick Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul R Edick has made a total of 9 transactions in Xeris Biopharma Holdings Inc (XERS) over the past 5 years, including 9 buys and 0 sells. The most-recent trade in Xeris Biopharma Holdings Inc is the acquisition of 10,000 shares on August 9, 2023, which cost Paul R Edick around $23,800.
According to the SEC Form 4 filings, Paul R Edick has made a total of 0 transactions in Iterum Therapeutics PLC (ITRM) over the past 5 years. The most-recent trade in Iterum Therapeutics PLC is the acquisition of 33 shares on August 23, 2018, which cost Paul R Edick around $5,220.
Insider Trading History of Paul R Edick
- 1
Paul R Edick Trading Performance
GuruFocus tracks the stock performance after each of Paul R Edick's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Paul R Edick is -7.7%. GuruFocus also compares Paul R Edick's trading performance to market benchmark return within the same time period. The performance of stocks bought by Paul R Edick within 3 months outperforms 5 times out of 11 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Paul R Edick's insider trading performs compared to the benchmark.
Performance of Paul R Edick
Average Return
-6.44%
Outperforming Transactions
40%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 2.96 | -7.7 | 6.72 | -6.44 | -33 | -33.66 |
| Relative Return to S&P 500(%) | 2.57 | -7.03 | 4.2 | -15.95 | -43.29 | -44.76 |
Paul R Edick Ownership Network
Ownership Network List of Paul R Edick
Ownership Network Relation of Paul R Edick
Paul R Edick Owned Company Details
What does Milestone Pharmaceuticals Inc do?
Who are the key executives at Milestone Pharmaceuticals Inc?
Paul R Edick is the director of Milestone Pharmaceuticals Inc. Other key executives at Milestone Pharmaceuticals Inc include Chief Medical Officer David Bharucha , 10 percent owner Roderick Wong , and 10 percent owner Rtw Investments, Lp .
Milestone Pharmaceuticals Inc (MIST) Insider Trades Summary
Over the past 18 months, Paul R Edick made no insider transaction in Milestone Pharmaceuticals Inc (MIST). Other recent insider transactions involving Milestone Pharmaceuticals Inc (MIST) include a net purchase of 14,000 shares made by Debra K. Liebert , a net purchase of 10,000 shares made by Richard C Pasternak , and a net purchase of 10,000 shares made by David Bharucha .
In summary, during the past 3 months, insiders sold 0 shares of Milestone Pharmaceuticals Inc (MIST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Milestone Pharmaceuticals Inc (MIST) were sold and 34,000 shares were bought by its insiders, resulting in a net purchase of 34,000 shares.
Milestone Pharmaceuticals Inc (MIST)'s detailed insider trading history can be found in Insider Trading Tracker table.
Milestone Pharmaceuticals Inc Insider Transactions
Paul R Edick Mailing Address
Above is the net worth, insider trading, and ownership report for Paul R Edick. You might contact Paul R Edick via mailing address: C/o Newlink Genetics Corp., 2503 South Loop Dr., Suite 5100, Ames Ia 50010.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
